In addition, the inclusion of genetic factors such as APOE genotype and Alzheimer’s disease–related blood biomarkers would be valuable to explore whether this ET subgroup shares biological vulnerability pathways with prodromal Alzheimer’s disease. The gene discussed is APOE; the disease is essential thrombocythemia.